Status:
WITHDRAWN
Performance of CAST (Cellular Antigen Stimulation Test) in Patients With Wasp Venom Allergy: Evaluation of Neutralizing IgG Subclasses
Lead Sponsor:
University of Zurich
Conditions:
Wasp Venom Allergic Patients
Eligibility:
All Genders
18-75 years
Brief Summary
To determine which subclass of IgG in the serum of patients undergoing SIT against wasp venom is able to neutralize the allergen, and therefore to prevent a positive CAST
Eligibility Criteria
Inclusion
- Inclusion criteria:
- male and female patient with allergy to wasp venom grade III and IV according to H.L. Müller
- 18-75 years
- planned SIT against wasp venom or finished 5 years SIT against wsp venom (10/10)
- Exclusion criteria:
- oral corticosteroids
- chromogycin
- ketotifen
- immunosuppressive drugs within the last 2 years
Exclusion
Key Trial Info
Start Date :
January 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00794287
Start Date
January 1 2009
Last Update
June 4 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zurich, Switzerland